Abstract
Objectives
Patients after surgery and radiation/chemoradiation for treatment of head and neck cancer often suffer from oral complications. These problems may be caused by surgery and radiation. Patients complain, for example, of swallowing problems and limited mouth opening (trismus).
Methods
The maximal interincisal mouth opening (MIO) was measured in patients treated with surgery and radiation/chemoradiation for head and neck cancer at the Department of Otorhinolaryngology at the University of Rostock. These patients also completed a 20-item questionnaire concerning nutritional, sensual, and speech disorders and pain.
Results
One hundred one patients (16 female and 85 male) returned the questionnaire and were included in the study. About 50% of the patients had a limited mouth opening (<36 mm); patients with oropharyngeal cancer had a significant higher risk for trismus (p = .024) than patients with other head and neck cancers, especially compared to patients with laryngeal cancer (p = .013). The questionnaire showed that especially patients with oral cancer report about problems with opening the mouth (73%), eating (65%), drinking (73%), xerostomia (92%), speech disorders (68%), and voice (62%). Patients with laryngeal cancer only reported about problems with xerostomia (62%), speech (83%), and voice (90%), similar to patients with pharyngeal cancer.
Conclusions
About half of the patients who underwent primary treatment for oral and oropharyngeal cancer developed trismus and reported about problems with opening the mouth, eating, drinking, dry mouth, voice, and speech. Trismus has a negative impact on quality of life and should be a focus in the postoperative management of patients with oral and oropharyngeal cancer, and, if diagnosed, special treatment should be initialized.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Patients with head and neck cancer often suffer from various complications after surgery and radiation/chemoradiation. While patients with laryngeal or pharyngeal cancer report about problems with speech and voice due to surgical techniques such as laryngectomy [1], patients with oral cancer complain about oral complications caused by radiation, such as dry mouth (xerostomia), swallowing problems, or limited mouth opening (trismus), as well as candidiasis and mucositis [2]. Radiotherapy (RT) is especially a main reason for oral complications like trismus. There are different opinions on the definition of trismus; some authors define trismus as a mouth opening less than 30 mm, other authors 40 mm [3]. Trismus is related to the dose of radiation [4]. Radiation-induced trismus appears in a high percentage of patients independent of other treatment modalities and has a proven negative impact on quality of life (QOL) [5]. The loss of function and range of mandibular motion appear to be related to damage and fibrosis to the muscles of mastication [6]. Different studies showed in up to 50% of patients with RT to the temporomandibular joint and the masseter muscle limitations in mouth opening [7]. Trismus is the main reason for other complications; it causes, for example, chewing and swallowing problems, which in turn cause weight loss with other resulting complications.
The aim of our study was to investigate the incidence of trismus in head and neck cancer patients after primary surgical therapy including (chemo)radiation and the impact on QOL. The results should be considered in preventive and postoperative management in head and neck cancer patients.
Methods
One hundred twenty-one patients were recruited from the head and neck cancer aftercare consultations at the Department of Head and Neck Surgery “Otto Körner”, University Hospital Rostock. All patients had biopsy-proven head and neck cancer and were treated with surgery and/or RT or radiochemotherapy (RCT). The patients completed a standardized 20-item questionnaire concerning QOL according to the EORTC QOL questionnaire (H&N35) [8]. They were asked nine questions about food intake, four questions about sensual alterations, three questions about speech disorders, and four questions about pain. Then the maximal interincisal opening (MIO) was measured using the Therabite® range of motion scale; a MIO less than 36 mm was considered to be limited. The patient data such as diagnosis, location, TNM status, and specific therapy were taken from the medical records. All data were entered in an SPSS database and statistical analyses consisted of χ 2 tests using SPSS for Windows 12.0.
Results
One hundred one patients, 16 female and 85 male, who had received primary therapy for head and neck cancer returned a modified EORTC QOL questionnaire for head and neck cancer patients; the clinical and sociodemographic data for these patients are shown in Table 1, the MIO measurement results are shown in Table 2, and the outcomes for the QOL questionnaire are shown in Table 3.
There were significant differences in limitations of mouth opening between oral/oropharyngeal and laryngeal cancer patients (p = .013), as well as between oral/oropharyngeal and other head and neck cancer patients (p = .024). A more advanced UICC stage was also associated with reduced mouth opening. Patients who received a higher radiation dose also showed higher incidence of limited mouth opening.
Discussion
Limited mouth opening (MIO)
This clinical trial showed that almost 50% of the 101 head and neck cancer patients who were evaluated presented with a limited mouth opening less than 36 mm; eight patients had a mouth opening less than 20 mm. Normal mouth opening should be 46 ± 7 mm; for our study, we chose a MIO less than 36 mm as trismus in analogy with O'Leary [9]. The average MIO in this study was 37.2 mm, which is similar to the results (36.7 mm) of Kent et al. [5], who researched on 40 head and neck cancer patients and identified trismus in 45%; their results showed that the trismus group reported more QOL deficits. Other trials showed a wide range (6–86%) in the incidence of trismus in head and neck cancer patients [10, 11]. These wide differences appear to be related to varying definitions and measurements of trismus in other trials, as well as the tumor localizations. In this trial, 65% of oral/oropharyngeal cancer patients showed a limited mouth opening, compared to 44% of hypopharyngeal cancer patients (p = .013) and 31% of laryngeal cancer patients; these differences were significant (p = .024). This may lead to the conclusion that the location of the tumor affects the mouth opening, as well as the field of radiation. The incidence of radiation-induced trismus depends on factors such as the total dose of radiation, fractionation, overall treatment time, and treatment technique. Teguh et al. [4] showed a relationship between mean radiation dose in masseter and pterygoid muscles and the probability of having trismus. Graff et al. [12] showed that intensity-modulated RT (IMRT) produces less oral complications than conventional RT. Radiation causes a loss of function by inducing fibrosis in the muscles of mastication, as well as necrosis of bone and soft tissue [6]. This fibrosis limits the mouth opening, with major effects on nutrition, dental hygiene, swallowing, and phonation. There is a proven relationship between trismus in head and neck cancer patients and QOL deficits [5]; these deficits result even in social exclusion and depression [10]. Duke et al. [13] demonstrated that oral complications and a poor dental status in irradiated head and neck cancer patients have a persistent impact on QOL, longer than other effects of cancer treatment. All this leads to the conclusion that head and neck cancer and especially oral/oropharyngeal cancer patients should be examined for oral complications in the aftercare management, and supportive treatment should be initialized. There are a few options for trismus therapy, such as tongue spatulas, Therabite Jaw Motion Rehabilitation System™, physical and thermal therapy, electrotherapy, and drugs (i.e., pentoxifylline, diazepam) [14].
Quality of life questionnaire
The QOL questionnaire showed that head and neck cancer patients report a lot of complications after primary therapy, such as xerostomia (80%), alteration of voice (69%), speech problems (67%), impairment of taste (54%), swallowing problems (52%), ingestion of food (50%), and limited opening the mouth (50%).
Especially patients with oral and oropharyngeal cancer complained about oral complications such as problems opening the mouth (73%), these results were significant compared to laryngeal cancer patients, of whom only 21% complained about trismus (p < .001), and to hypopharyngeal cancer patients, of whom 31% reported limited mouth opening (p = .011). These questionnaire results were similar to the measurements of limited mouth opening, as well as to the results of Bjordal et al. [15] (Table 4). They also report about more problems with mouth opening in patients with oral and oropharyngeal cancer and less problems in patients with pharyngeal and laryngeal cancer.
Patients with oral and oropharyngeal cancer reported about problems with eating (65%) and drinking (70%) that are related to the reduced mouth opening; intake or ingestion is restricted by limited jaw opening. The secondary effects are weight loss and dental hygiene with a negative impact on QOL and contribution to depression [10].
Radiation therapy for oropharyngeal cancer affects the salivary glands causing xerostomia. This was reported by 92% of the patients with oral and oropharyngeal cancer. Sixty-two percent of laryngeal cancer patients complained about xerostomia and 69% of the patients with hypopharyngeal cancer. Dirix et al. [16] showed similar results (93% of oral cancer patients) in their research on xerostomia, with a proven impact on QOL.
Another negative impact on QOL reported by oral and oropharyngeal cancer patients in this questionnaire is the impairment of speech (68%). Talmi [17] reported about speech disorders following RT and surgery for oral cancer. This may be related to hypomobility of the tongue after treatment, but limited mouth opening may also play a role. Laryngeal cancer patients complained in 83% of speech disorders, due to surgery or RT to the larynx [18].
Other disorders or problems reported by more than 50% of patients with oral and oropharyngeal cancer were alteration of voice (62%), change of sense of taste (60%), chewing problems (60%), impaired swallowing (60%), choking on food (54%), and coughing while eating (52%). Surprisingly, only 11% of these patients needed analgesic drugs, while other authors reported chronic pain in 42% of oral cancer patients [19].
Head and neck cancer patients suffer from a lot of complications, disorders, and problems affecting QOL. The main problems for patients with oral and oropharyngeal cancer in this trial were xerostomia, limited mouth opening, drinking and eating disorders, as well as speech problems. Concerning limited mouth opening or trismus, patients often suffer from secondary effects such as weight loss, malnutrition, and poor dental hygiene. To avoid these complications and to improve QOL, we should consider these problems during posttreatment management of these patients. If limited mouth opening is diagnosed, supportive therapy should be initialized.
References
Houser A, Kramp B, Richter J, Däßler U (2001) Quality of life for patients with head and neck cancer, especially following laryngectomy. Laryngo Rhino Otol 80:458–463
Jham BC, Reis PM, Miranda EL, Lopes RC, Carvalho AL, Scheper MA et al (2008) Oral health status of 207 head and neck cancer patients before, during and after radiotherapy. Clin Oral Investig 12:19–24
Dijkstra PU, Huisman PM, Roodenburg JL (2006) Criteria for trismus in head and neck oncology. Int J Oral Maxillofac Surg 35:337–342
Teguh DN, Levendag PC, Voet P, van der Est H, Noever I, de Kruijf W et al (2008) Trismus in patients with oropharyngeal cancer: relationship with dose in structures of mastication apparatus. Head Neck 30:622–630
Kent ML, Brennan MT, Noll JL, Fox PC, Burri SH, Hunter JC et al (2008) Radiation-induced trismus in head and neck cancer patients. Support Care Cancer 16:305–309
Wang CJ, Huang EY, Hsu HC, Chen HC, Fang FM, Hsiung CY (2005) The degree and time-course assessment of radiation-induced trismus occurring after radiotherapy for nasopharyngeal cancer. Laryngoscope 115:1458–1460
Bhrany AD, Izzard M, Wood AJ, Futran ND (2007) Coronoidectomy for the treatment of trismus in head and neck cancer patients. Laryngoscope 117(11):1952–1956
Singer S, Woolbrück D, Wulke C, Dietz A, Klemm E, Oeken J et al (2009) Validation of the EORTC QLQ-C30 and EORTC QLQ-H&N35 in patients with laryngeal cancer after surgery. Head Neck 31:64–76
O'Leary MR (1990) Trismus: modern pathophysiological correlates. Am J Emerg Med 8:220–227
Goldstein M, Maxymiw WG, Cummings BJ, Wood RE (1999) The effects of antitumor irradiation on mandibular opening and mobility: a prospective study of 58 patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 88:365–373
Whitmyer CC, Waskowski JC, Iffland HA (1997) Radiotherapy and oral sequelae: preventive and management protocols. J Dent Hyg 71:23–29
Graff P, Lapeyre M, Desandes E, Ortholan C, Bensadoun RJJ, Alfonsi M et al (2007) Impact of intensity-modulated radiotherapy on health-related quality of life for head and neck cancer patients: matched-pair comparison with conventional radiotherapy. Int J Radiat Oncol Biol Phys 67:1309–1317
Duke RL, Campbell BH, Indresano TA, Eaton DJ, Marbella AM, Myers KB et al (2005) Dental status and quality of life in long-term head and neck cancer survivors. Laryngoscope 115:678–683
Garnett MJ, Nohl FS, Barclay SC (2008) Management of patients with reduced oral aperture and mandibular hypomobility (trismus) and implications for operative dentistry. Br Dent J 204:125–131
Bjordal K, Ahlner-Elmqvist M, Hammerlid E, Boysen M, Evensen JF, Biörklund A et al (2001) A prospective study of quality of life in head and neck cancer patients. Part II: Longitudinal data. Laryngoscope 111:1440–1452
Dirix P, Nuyts S, Van der Poorten V, Delaere P, Van den Bogaert W (2008) The influence of xerostomia after radiotherapy on quality of life: results of a questionnaire in head and neck cancer. Support Care Cancer 16:171–179
Talmi YP (2002) Quality of life issues in cancer of the oral cavity. J Laryngol Otol 116:785–790
Biazevic MG, Antunes JL, Togni J, de Andrade FP, de Carvalho MB, Wünsch-Filho V (2008) Immediate impact of primary surgery on health-related quality of life of hospitalized patients with oral and oropharyngeal cancer. J Oral Maxillofac Surg 66:1343–1350
Bindewald J, Oeken J, Wollbrueck D, Wulke C, Dietz A, Herrmann E et al (2007) Quality of life correlates after surgery for laryngeal carcinoma. Laryngoscope 117:1770–1776
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Weber, C., Dommerich, S., Pau, H.W. et al. Limited mouth opening after primary therapy of head and neck cancer. Oral Maxillofac Surg 14, 169–173 (2010). https://doi.org/10.1007/s10006-010-0220-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10006-010-0220-2